125 related articles for article (PubMed ID: 9359703)
1. A novel protein that participates in nonself discrimination of malignant cells by homologous complement.
Matsumoto M; Takeda J; Inoue N; Hara T; Hatanaka M; Takahashi K; Nagasawa S; Akedo H; Seya T
Nat Med; 1997 Nov; 3(11):1266-70. PubMed ID: 9359703
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes.
Matsumoto M; Nishiguchi M; Kikkawa S; Nishimura H; Nagasawa S; Seya T
J Biol Chem; 1998 May; 273(20):12407-14. PubMed ID: 9575196
[TBL] [Abstract][Full Text] [Related]
3. M161Ag is a potent cytokine inducer with complement activating function (review).
Matsumoto M; Seya T
Int J Mol Med; 1999 Mar; 3(3):291-5. PubMed ID: 10028054
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
5. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.
Matsumoto M; Yamashita F; Iida K; Tomita M; Seya T
J Exp Med; 1995 Jan; 181(1):115-25. PubMed ID: 7806998
[TBL] [Abstract][Full Text] [Related]
7. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
Matsumoto M; Sugita Y; Seya T
Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
[TBL] [Abstract][Full Text] [Related]
8. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells.
Elward K; Griffiths M; Mizuno M; Harris CL; Neal JW; Morgan BP; Gasque P
J Biol Chem; 2005 Oct; 280(43):36342-54. PubMed ID: 16087667
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
10. Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.
Kurita M; Matsumoto M; Tsuji S; Kawakami M; Suzuki Y; Hayashi H; Toyoshima K; Seya T
Clin Exp Immunol; 1999 Jun; 116(3):547-53. PubMed ID: 10361249
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loop.
Rösner T; Lohse S; Peipp M; Valerius T; Derer S
J Immunol; 2014 Aug; 193(3):1485-95. PubMed ID: 24973443
[TBL] [Abstract][Full Text] [Related]
12. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
13. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
Nomura M; Kurita-Taniguchi M; Kondo K; Inoue N; Matsumoto M; Yamanishi K; Okabe M; Seya T
Eur J Immunol; 2002 Oct; 32(10):2954-64. PubMed ID: 12355449
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
16. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
17. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.
Nishiguchi M; Matsumoto M; Takao T; Hoshino M; Shimonishi Y; Tsuji S; Begum NA; Takeuchi O; Akira S; Toyoshima K; Seya T
J Immunol; 2001 Feb; 166(4):2610-6. PubMed ID: 11160323
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
19. [Cell-associated complement regulatory proteins and their relation to disease processes].
Seya T
Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
[TBL] [Abstract][Full Text] [Related]
20. The role of the complement system in cancer.
Afshar-Kharghan V
J Clin Invest; 2017 Mar; 127(3):780-789. PubMed ID: 28248200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
